BioCentury
ARTICLE | Company News

AviGenics, Geron, Origen Therapeutics Inc. deal

January 2, 2001 8:00 AM UTC

AviGenics and Origen received options for non-exclusive worldwide licenses to GERN's nuclear transfer technology for avian applications (developing cloned poultry). The companies will use the GERN tec...